Legend Biotech Corp (LEGN) Stock Analysis

Legend Biotech Corp (LEGN) is a publicly traded company in the HEALTHCARE sector. It trades at $36.28, carries a market capitalization of $4.74B. This page summarizes the public market data, fundamentals, and frequently asked questions for LEGN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Legend Biotech Corp currently has a Bullish sentiment score of 0.36.

About Legend Biotech Corp

Legend Biotech Corporation is a clinical-stage biopharmaceutical company dedicated to pioneering innovative cell therapies, particularly in oncology, through its proprietary CAR-T cell therapy platform. With a robust pipeline and a commitment to rigorous clinical research, the company is well-positioned to address substantial unmet medical needs and enhance patient outcomes. Strategic collaborations further strengthen its capabilities, making Legend Biotech a compelling prospect for instituti...

GNG Research Analysis

GNG Research scores Legend Biotech Corp (LEGN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for LEGN.

Frequently Asked Questions

Does LEGN pay dividends?

Legend Biotech Corp (LEGN) does not currently pay a regular dividend.

What is LEGN's market cap?

Legend Biotech Corp (LEGN) has a market capitalization of $4.74B with a current stock price of $36.28.